The South African division of Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., achieved its largest revenue month in the company’s history for this region during March 2022.
“2022 has been a truly remarkable year for sales in South Africa so far,” said Medical Marijuana, Inc. CEO Blake Schroeder. “We’re excited about our very rapid growth in the market and look forward to continued growth not only in South Africa but also our expansion throughout the continent as cannabis becomes legally accepted and free access continues to be newly enabled.”
